Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRtw Biotech Regulatory News (RTW)

Share Price Information for Rtw Biotech (RTW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.32
Bid: 1.31
Ask: 1.325
Change: 0.00 (0.00%)
Spread: 0.015 (1.145%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.32
RTW Live PriceLast checked at -
RTW Venture is an Investment Trust

To achieve positive absolute performance and superior long-term capital appreciation, with a focus on forming, building, and supporting world-class life sciences, biopharmaceutical and medical technology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

14 Feb 2020 07:00

RNS Number : 9834C
RTW Venture Fund Limited
14 February 2020
 

LEI: 549300Q7EXQQH6KF7Z84

14 February 2020

RTW Venture Fund Limited

Net Asset Value

RTW Venture Fund Limited (the "Company") announces that the unaudited net asset value of the Company at the close of business on 31 January 2020 (the "NAV") was US$207.65 million, or US$1.22 per ordinary share.

As at 31 January 2020, 15.1 per cent. of the NAV was invested in privately-held companies.

For Further Information

RTW Investments, LP +1 (646) 343 9280Stephanie Sirota, Chief Business Officer

Alexandra Taracanova, PhD, Director of Investor Relations

Julia Enright, Business Development Associate

 

Estera (Company Secretary) +44 (0)1481 742 642Kevin Smith

 

Note:

1.

The NAV is determined by the Company's investment manager, RTW Investments, LP, in accordance with the Company's accounting policies. Investments by the Company in privately-held companies ("Private Portfolio Companies") have been valued at fair market value, taking into account the valuation prepared by Alvarez & Marsal Valuation Services LLC as at 31 January 2020 and the nature, facts and circumstances of the Private Portfolio Companies since that date. Investments by the Company in companies listed on a public stock exchange (the "Public Portfolio Companies") have each been valued by reference to their market capitalisation as at close of business on 31 January 2020. The Company applies a valuation discount to its investments in Public Portfolio Companies that are subject to post-IPO lock-up provisions.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NAVGPUWWPUPUGBW
Date   Source Headline
28th Mar 20247:01 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSAnnual Financial Report
27th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:01 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSMonthly Valuation Update & Factsheet
11th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTotal Voting Rights
29th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSClosed Period Notification
22nd Feb 20243:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20243:54 pmRNSHolding(s) in Company
20th Feb 20245:47 pmRNSPost-transaction Manager NAV Estimate
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20244:50 pmRNSHolding(s) in Company
16th Feb 20249:45 amRNSHolding(s) in Company
14th Feb 20247:01 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSMonthly Valuation Update, January Factsheet
13th Feb 20248:11 amRNSCompletion of Acquisition
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:01 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSRTW Biotech Opp. – Investment Update: Kyverna IPO
1st Feb 20247:00 amRNSTotal Voting Rights
31st Jan 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSUpdate on Arix Transaction
24th Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSAcacia stake purchase & capital allocation plan
18th Jan 20247:00 amRNSTransaction in Own Shares
15th Jan 20247:00 amRNSMonthly Valuation Update, December Factsheet
10th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20249:00 amRNSInvestment Update
5th Jan 20241:00 pmRNSPublication of a Prospectus
2nd Jan 20247:00 amRNSTotal Voting Rights
14th Dec 20237:00 amRNSMonthly Valuation Update, November Factsheet
6th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 20237:01 amRNSTotal Voting Rights
1st Dec 20237:00 amRNSTransaction in Own Shares
13th Nov 20237:00 amRNSPortfolio Company Update: CARGO Therapeutics, Inc
13th Nov 20237:00 amRNSTransaction in Own Shares
13th Nov 20237:00 amRNSMonthly Valuation Update, October Factsheet
9th Nov 20237:00 amRNSTransaction in Own Shares
8th Nov 20237:00 amRNSTransaction in Own Shares
1st Nov 202310:51 amEQSEdison issues flash on RTW Biotech Opportunities (RTWBIO): Significant acquisition of Arix Bioscience’s assets
1st Nov 20237:06 amRNSRTW Biotech to acquire Arix Bioscience's assets
1st Nov 20237:05 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.